Top Clinical Trials companies in India by Operating Income Margin

This ranking features the top 13 Clinical Trials companies in India ranked by Operating Income Margin, averaging a Operating Income Margin of -113.34%, for February 08, 2025.
#
Name
Operating Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
38.87%
March 31, 2024 USD 32.02 -0.02%

India

2
33.78%
March 31, 2024 USD 7.16 0.59%

India

3
18.54%
March 31, 2024 USD 8.48 -0.45%

India

4
16.84%
March 31, 2024 USD 20.94 -0.93%

India

5
16.21%
March 31, 2024 USD 8.93 -4.20%

India

6
15.68%
March 31, 2024 USD 1.17 -2.09%

India

7
7.81%
March 31, 2024 USD 11.39 -5.33%

India

8
5.50%
March 31, 2024 USD 17.54 2.44%

India

9
3.11%
March 31, 2024 USD 0.56 -2.22%

India

10
-4.12%
March 31, 2024 USD 11.74 -1.33%

India

11
-32.54%
March 31, 2024 USD 0.13 -2.33%

India

12
-544.71%
March 31, 2024 USD 1.80 -0.88%

India

13
-1,048.35%
March 31, 2024 USD 1.50 0.58%

India

Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Operating Income Margin ?

    The Clinical Trials company in India with the highest Operating Income Margin is Dr. Lal PathLabs Limited (NSE: LALPATHLAB.NS) at 38.87%.

  • Which Clinical Trials company in India has the lowest Operating Income Margin ?

    The Clinical Trials company in India with the lowest Operating Income Margin is Suven Life Sciences Limited (NSE: SUVEN.NS) at -1,048.35%.

SV Wall Street